drugset / Trial / NCT02971800
Evaluation of Sodium Fluorescein Use During Intraoperative Cystoscopy After Total Laparoscopic Hysterectomy
NaSingle-groupOpen-labelDiagnostic
Summary
The primary objective is to describe the safety and efficacy of intravenous sodium fluorescein to visualize ureteral efflux during intraoperative cystoscopy after total laparoscopic hysterectomy. Secondary objective is to report on surgeon's satisfaction with the overall use of sodium fluorescein.
Timeline
- Start
- 2016-08
- Primary completion
- 2017-01
- Completion
- 2017-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sodium Fluorescein | Diagnostic / imaging agent | 25 mg | Intravenous |
Indications
No indication recorded.